ANI acquires six generics, related agreements, and equipment
ANI Pharmaceuticals has completed its acquisition of six generic products, related manufacturing and supply agreements, and equipment from Amneal Pharmaceuticals and Impax Laboratories.
Archives for May 8, 2018
Roivant to integrate monARC clinical trials tech with its drug development platform
monARC Bionetworks has announced an integration with Roivant’s drug development platform, as part of which the healthcare technology provider will receive a strategic investment.
EHR provider athenahealth reviewing $6.9bn acquisition offer
The company, which has partnerships to support clinical trials recruitment, has received an unsolicited acquisition offer from Elliott Management – skyrocketing the EHR provider’s stock.
FDA approves simultaneous administration of Tafinlar, Mekinist for ATC
Novartis has received approval for the administration of Tafinlar and Mekinist together for the treatment of anaplastic thyroid cancer (ATC).
Affimers provide new insight into cells while satisfying commitment to animals
Scientists at the University of Leeds may have found a new way to reduce the number of animals used in research while also gaining improved insight into treating cancer and other diseases.
Takeda secures Shire bid for $62.11bn
Takeda has acquired Shire for approximately $62.11bn (£46bn) to create a Japan-headquartered biopharmaceutical company with a robust pipeline and expanded geographical footprint.